Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dieter Haering"'
Autor:
Dieter Haering, Jens Kuhle, Davorka Tomic, Ludwig Kappos, Christian Barro, Uma Kundu, Maria Pia Sormani, David Leppert, Harald Kropshofer
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, Vol 6, Iss 6, Pp 1081-1089 (2019)
Annals of Clinical and Translational Neurology, Vol 6, Iss 6, Pp 1081-1089 (2019)
Objectives To assess whether neurofilament light chain (NfL) could serve as an informative endpoint in Phase 2 studies in patients with relapsing–remitting multiple sclerosis (RRMS) and estimate the sample size requirements with NfL as the primary
Autor:
Ludwig Kappos, Dieter Haering, Davorka Tomic, Jens Kuhle, Frank Dahlke, Harald Kropshofer, Rolf Meinert, Christian Barro, David Leppert, Uma Kundu
Publikováno v:
Neurology
ObjectiveTo assess the value of blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage and its utility to monitor treatment response in relapsing-remitting multiple sclerosis.MethodsWe m
Autor:
Dieter Haering, Nicola De Stefano, Gavin Giovannoni, Dawn Langdon, Ludwig Kappos, Maria Pia Sormani, Davorka Tomic, Daniela Piani-Meier
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry
ObjectiveTo assess the prognostic value of practice effect on Paced Auditory Serial Addition Test (PASAT) in multiple sclerosis.MethodsWe compared screening (day −14) and baseline (day 0) PASAT scores of 1009 patients from the FTY720 Research Evalu
Autor:
Dieter Haering, P Connor, Ernst-Willhelm Radue, Ludwig Kappos, Maria Pia Amato, Lixin Zhang-Auberson, Gordon Francis, Eli Silber
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 85:e4.54-e4
Objectives To evaluate the long-term efficacy outcomes in patients with high-disease-activity switching from placebo to fingolimod, from the FREEDOMS extension study. Methods Patients either continued on the fingolimod dose assigned in the core phase